Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet — manufactured by Trumac Healthcare

Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Myo-inositol 600 MG + Metformin 500 mg (As sustained release)
Form: Tablet
Class: Inositol + Biguanide PCOS Combo
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Myowell-M SR Tablet

Myowell-M SR Tablet

Pack: 10 x 10 (Blister)

MRP: ₹1800

View Myowell-M SR Tablet →

Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Myo-inositol 600 MG + Metformin 500 mg (As sustained release) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Insulin-resistant PCOS
  • PCOS with obesity
  • Prediabetic PCOS (HOMA-IR >2.5)
  • PCOS unresponsive to Myo-Inositol alone
Mechanism of Action

Myo-Inositol is a sugar alcohol that acts as second messenger for FSH/insulin signalling — improves ovarian response to FSH, restores ovulation in PCOS, improves oocyte quality, and reduces hyperandrogenism. D-Chiro-Inositol is the chirally distinct stereoisomer with complementary insulin-sensitising action — physiological ratio 40:1 (Myo:DCI) considered optimal. Metformin reduces hepatic glucose output and improves peripheral insulin sensitivity — complementary to ovarian Myo-Inositol action.

Dosage & Administration
  • Adults: 1 tablet once or twice daily with meals.
Side Effects
  • GI upset (Metformin — improves over 2–4 weeks), metallic taste.
Contraindications
  • eGFR <30 ml/min, acute illness with dehydration, recent IV contrast, hypersensitivity.
Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise for Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 10 (Blister)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet?

Available pack sizes include: 10 x 10 (Blister).

What is the MRP / trade price for Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet?

MRPs range from ₹1800 to ₹1800 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Myo-inositol 600 MG + Metformin 500 mg (As sustained release) Tablet?

Get Pricing & Franchise Terms →